Impact of age at vaccination and cervical HPV infection status on binding and neutralizing antibody titers at 10 years after receiving single or higher doses of quadrivalent HPV vaccine

• Main Authors: Neerja Bhatla (Author), Richard Muwonge (Author), Sylla G. Malvi (Author), Smita Joshi (Author), Usha Rani Reddy Poli (Author), Eric Lucas (Author), Pulikkottil O. Esmy (Author), Yogesh Verma (Author), Anand Shah (Author), Eric Zomawia (Author), Sharmila Pimple (Author), Kasturi Jayant (Author), Sanjay Hingmire (Author), Aruna Chiwate (Author), Shachi Vashist (Author), Gauravi Mishra (Author), Radhika Jadhav (Author), Maqsood Siddiqi (Author), Devasena Anantharaman (Author), Gitika Panicker (Author), Julia Butt (Author), Subha Sankaran (Author), Thiraviam Pillai Rameshwari Ammal Kannan (Author), Rintu Varghese (Author), Purnima Kartha (Author), M. Radhakrishna Pillai (Author), Tim Waterboer (Author), Martin Müller (Author), Peter Sehr (Author), Elizabeth R. Unger (Author), Rengaswamy Sankaranarayanan (Author), Partha Basu (Author)
• Format: Book
• Published: Taylor & Francis Group, 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

ABSTRACTLong-term follow-up of a cohort of unmarried girls who received one, two, or three doses of quadrivalent HPV vaccine, between 10 and 18 years of age, in an Indian multi-centric study allowed us to compare antibody responses between the younger and older age cohorts at 10-years post-vaccinati...